These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23564022)

  • 21. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
    Maron BJ; Maron MS; Wigle ED; Braunwald E
    J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.
    Güçlü A; Happé C; Eren S; Korkmaz IH; Niessen HW; Klein P; van Slegtenhorst M; Schinkel AF; Michels M; van Rossum AC; Germans T; van der Velden J
    Eur J Clin Invest; 2015 Dec; 45(12):1252-9. PubMed ID: 26444145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biphasic left ventricular outflow and its mechanism in hypertrophic obstructive cardiomyopathy.
    Conklin HM; Huang X; Davies CH; Sahn DJ; Shively BK
    J Am Soc Echocardiogr; 2004 Apr; 17(4):375-83. PubMed ID: 15044873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic change of mitral apparatus as potential cause of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Hwang HJ; Choi EY; Kwan J; Kim SA; Shim CY; Ha JW; Rim SJ; Chung N; Kim SS
    Eur J Echocardiogr; 2011 Jan; 12(1):19-25. PubMed ID: 20693545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study.
    Tigen K; Sunbul M; Karaahmet T; Dundar C; Ozben B; Guler A; Cincin A; Bulut M; Sari I; Basaran Y
    Echocardiography; 2014 Aug; 31(7):833-41. PubMed ID: 24341920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction.
    Le Tourneau T; Susen S; Caron C; Millaire A; Maréchaux S; Polge AS; Vincentelli A; Mouquet F; Ennezat PV; Lamblin N; de Groote P; Van Belle E; Deklunder G; Goudemand J; Bauters C; Jude B
    Circulation; 2008 Oct; 118(15):1550-7. PubMed ID: 18809794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
    Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A
    J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Kubo T; Okumiya T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Sugiura T; Doi YL; Kitaoka H
    J Cardiol; 2016 Mar; 67(3):274-8. PubMed ID: 26254020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients.
    Dhillon A; Sweet W; Popovic ZB; Smedira NG; Thamilarasan M; Lytle BW; Tan C; Starling RC; Lever HM; Moravec CS; Desai MY
    J Am Heart Assoc; 2014 Nov; 3(6):e001269. PubMed ID: 25389286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Jensen MK; Havndrup O; Pecini R; Dalsgaard M; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Eur J Echocardiogr; 2010 Oct; 11(9):763-9. PubMed ID: 20472917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of left ventricular outflow area in patients with hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study.
    Fukuda S; Lever HM; Stewart WJ; Tran H; Song JM; Shin MS; Greenberg NL; Wada N; Matsumura Y; Toyono M; Smedira NG; Thomas JD; Shiota T
    J Am Soc Echocardiogr; 2008 Jul; 21(7):789-95. PubMed ID: 18325733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction.
    Malik R; Maron MS; Rastegar H; Pandian NG
    Echocardiography; 2014 May; 31(5):682-5. PubMed ID: 24649889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic cardiomyopathy in childhood: disease natural history, impact of obstruction, and its influence on survival.
    Hickey EJ; McCrindle BW; Larsen SH; Benson L; Manlhiot C; Caldarone CA; Van Arsdell GS; McCrindle BM; Williams WG
    Ann Thorac Surg; 2012 Mar; 93(3):840-8. PubMed ID: 22284306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Mean Platelet Volume in Familial Hypercholesterolemia.
    Icli A; Aksoy F; Nar G; Kaymaz H; Alpay MF; Nar R; Guclu A; Arslan A; Dogan A
    Angiology; 2016 Feb; 67(2):146-50. PubMed ID: 25859052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.
    Timmer SA; Knaapen P; Germans T; Lubberink M; Dijkmans PA; Vonk-Noordegraaf A; Ten Berg JM; Ten Cate FJ; Lammertsma AA; van Rossum AC
    J Card Fail; 2011 Oct; 17(10):827-31. PubMed ID: 21962421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy.
    Barac I; Upadya S; Pilchik R; Winson G; Passick M; Chaudhry FA; Sherrid MV
    J Am Coll Cardiol; 2007 Mar; 49(11):1203-11. PubMed ID: 17367665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.